ABVC Biopharma Financials
| ABVC Stock | USD 0.66 0.01 1.54% |
ABVC |
Understanding current and past ABVC Biopharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ABVC Biopharma's financial statements are interrelated, with each one affecting the others. For example, an increase in ABVC Biopharma's assets may result in an increase in income on the income statement.
Please note, the presentation of ABVC Biopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABVC Biopharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ABVC Biopharma's management manipulating its earnings.
ABVC Biopharma Stock Summary
ABVC Biopharma competes with Indaptus Therapeutics, Pasithea Therapeutics, Forte Biosciences, Akari Therapeutics, and Aditxt. ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation. Abvc Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US00091F1066 |
| CUSIP | 00091F106 00091F304 278880208 278880109 024733206 |
| Location | California; U.S.A |
| Business Address | 44370 Old Warm |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.abvcpharma.com |
| Phone | 510 668 0881 |
| Currency | USD - US Dollar |
ABVC Biopharma Key Financial Ratios
ABVC Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ABVC Biopharma's current stock value. Our valuation model uses many indicators to compare ABVC Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABVC Biopharma competition to find correlations between indicators driving ABVC Biopharma's intrinsic value. More Info.ABVC Biopharma is rated below average in return on equity category among its peers. It is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ABVC Biopharma's earnings, one of the primary drivers of an investment's value.ABVC Biopharma Systematic Risk
ABVC Biopharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ABVC Biopharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on ABVC Biopharma correlated with the market. If Beta is less than 0 ABVC Biopharma generally moves in the opposite direction as compared to the market. If ABVC Biopharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ABVC Biopharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ABVC Biopharma is generally in the same direction as the market. If Beta > 1 ABVC Biopharma moves generally in the same direction as, but more than the movement of the benchmark.
About ABVC Biopharma Financials
What exactly are ABVC Biopharma Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include ABVC Biopharma's income statement, its balance sheet, and the statement of cash flows. Potential ABVC Biopharma investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although ABVC Biopharma investors may use each financial statement separately, they are all related. The changes in ABVC Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ABVC Biopharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.ABVC Biopharma March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ABVC Biopharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ABVC Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of ABVC Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing ABVC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ABVC Biopharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.21 | |||
| Information Ratio | 0.1074 | |||
| Maximum Drawdown | 32.39 | |||
| Value At Risk | (8.70) | |||
| Potential Upside | 14.08 |
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |